TY - JOUR
T1 - Azacitidine-induced myopericarditis in acute myeloid leukemia
AU - Ismayl, Mahmoud
AU - KC, Asmini
AU - Thandra, Abhishek
AU - Sricharoen, Nattapong
AU - Arouni, Amy
N1 - Publisher Copyright:
© Copyright © 2022 Baylor University Medical Center.
PY - 2022
Y1 - 2022
N2 - Hypomethylating agents are commonly used in the treatment of myelodysplastic syndromes and are known to cause bone marrow suppression; however, cardiac complications are rare. We describe a patient who was diagnosed with acute myeloid leukemia and developed myopericarditis after receiving chemotherapy with azacitidine. Our case highlights the importance of a thorough history, including medication review, in patients with suspected myopericarditis. It also raises awareness about the potential cardiac side effects of azacitidine.
AB - Hypomethylating agents are commonly used in the treatment of myelodysplastic syndromes and are known to cause bone marrow suppression; however, cardiac complications are rare. We describe a patient who was diagnosed with acute myeloid leukemia and developed myopericarditis after receiving chemotherapy with azacitidine. Our case highlights the importance of a thorough history, including medication review, in patients with suspected myopericarditis. It also raises awareness about the potential cardiac side effects of azacitidine.
UR - http://www.scopus.com/inward/record.url?scp=85136095571&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136095571&partnerID=8YFLogxK
U2 - 10.1080/08998280.2022.2111642
DO - 10.1080/08998280.2022.2111642
M3 - Article
AN - SCOPUS:85136095571
JO - Baylor University Medical Center Proceedings
JF - Baylor University Medical Center Proceedings
SN - 0899-8280
ER -